James Paul Scopa is of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 100,000 shares of ADVM, which is worth approximately $474,000. The most recent transaction as insider was on Feb 07, 2024, when has been sold 100,000 shares (Common Stock) at a price of $1.35 per share, resulting in proceeds of $135,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
0% 3M change
n/a 12M change
Total Value Held $474,000

James Paul Scopa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
BUY
Open market or private purchase
$135,000 $1.35 p/Share
100,000 Added 50.0%
100,000 Common Stock

Also insider at

ALGS
Aligos Therapeutics, Inc. Healthcare
DICE
DICE Therapeutics, Inc. Healthcare
JPS

James Paul Scopa

South San Francisco, CA

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM